United Kingdom· GB-APID-21325411000001108

SilDerm scar gel

A medicinal product containing silicone, registered in United Kingdom by Aspire Pharma Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedSilDerm scar gelATC—REGISTER NO.GB-APID-2132541100000…PACKS LISTED2CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Silicone
Manufacturer
Aspire Pharma Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5060295490059
  • gtin
    5060295490035

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Silicone in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All silicone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b5cdbe72-c115-46f8-8883-d9d4aeee4a18
GET /v1/drugs/b5cdbe72-c115-46f8-8883-d9d4aeee4a18?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "21325411000001108",
  "desc": "SilDerm scar gel (Aspire Pharma Ltd)",
  "form": null,
  "vpid": "3434811000001105",
  "source": "dmd",
  "vtm_id": "777528002",
  "strength": null,
  "substance": "Silicone",
  "ingredient": null,
  "supplier_code": "16666911000001109"
}

See everything about silicone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.